Please login to the form below
British Business Bank
This page shows the latest British Business Bank news and features for those working in and with pharma, biotech and healthcare.
UK biotech funding falls 40% between 2018 and 2019
Government efforts to leverage new scale-up capital through the British Business Bank and the UK pension funds industry should be stepped up, as should grant funding for early-stage companies
Latest news
-
Johnson pledges £200m cash injection into UK’s life sciences sector
In addition, the British Business Bank is set to launch a new dedicated fund to support the development of UK-based health and life sciences companies. ... Steve Bates. “The BIA is meeting with the British Business Bank in October and will press to
-
Budget 2018: UK life sciences sector delivers its verdict
The government says it will provide the British Business Bank with the resources to make up to £200m of additional investment in UK venture capital and growth finance in fiscal ... Thompson. The BioIndustry Association (BIA) also welcomed the extra NHS
-
What’s in store in the final (maybe short-lived) pre-Brexit budget?
This is likely to include an assessment of tax changes to encourage investment, a report on the activities of the British Business Bank and progress on work with the pension funds
-
British Business Bank sets up £2.5bn fund for ‘unicorn’ firms
British Patient Capital - which was pledged by Chancellor Philip Hammond last autumn and run by the British Business Bank - aims to support companies with high-growth potential and plug the deficit ... So, British Patient Capital will provide an extra £2
More from news
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns
- WHO releases interim statement on COVID-19 vaccination for children and adolescents
- Novartis reports death of two patients treated with Zolgensma
- The impact of COVID-19 on the fight against AMR
- NHS bowel cancer checks reach record-high following death of Dame Deborah James
- Environment: where does the pharmaceutical industry stand?
- Moderna’s Omicron booster receives MHRA approval
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Achieving communication excellence by targeting the right channel at the right time
- Environment: where does the pharmaceutical industry stand?
- FDA approves Incyte’s Pemazyre as first targeted drug for bile duct cancer
- Novartis reports death of two patients treated with Zolgensma
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
